BLTE Stock Price History and Quote Analysis: Insights for Investors
Belite Bio, Inc
Stock Price Today
Belite Bio, Inc (BLTE) stock surged +0.18%, trading at $50.99 on NASDAQ, up from the previous close of $50.90. The stock opened at $50.98, fluctuating between $50.49 and $51.15 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
Company Information
| Employees | 20 |
| Beta | -1.491 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Belite Bio, Inc (NASDAQ: BLTE) stock price is $50.99 in the last trading session. During the trading session, BLTE stock reached the peak price of $51.15 while $50.49 was the lowest point it dropped to. The percentage change in BLTE stock occurred in the recent session was 0.18% while the dollar amount for the price change in BLTE stock was $0.09.
The NASDAQ listed BLTE is part of Biotechnology industry that operates in the broader Healthcare sector. Belite Bio, Inc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Nathan L. Mata Ph.D.
Chief Scientific Officer
Ms. Ching-Chen Chiu M.Sc.
Vice President of Clinical Operations
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Chairman of Directors & Chief Executive Officer
Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.
Chief Financial Officer & Director
BLTE's closing price is 78.85% higher than its 52-week low of $28.51 where as its distance from 52-week high of $51.15 is -0.31%.
Number of BLTE employees currently stands at 20.
Official Website of BLTE is: https://belitebio.com
BLTE could be contacted at phone 858 246 6240 and can also be accessed through its website. BLTE operates from 5820 Oberlin Drive, San Diego, CA 92121, United States.
BLTE stock volume for the day was 50.03K shares. The average number of BLTE shares traded daily for last 3 months was 31.23K.
The market value of BLTE currently stands at $1.56B with its latest stock price at $50.99 and 30.61M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com